ENTITY
Ocumension Therapeutics

Ocumension Therapeutics (1477 HK)

34
Analysis
Health CareChina
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
02 Dec 2020 09:36

Harbour Biomed IPO: Positive Thoughts in Brief

This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.

Share
24 Oct 2020 23:47

What HKEX Biotech "Step-Ups" Can Tell Us

This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...

Share
22 Sep 2020 12:37

Joy Spreader (乐享互动) Trading - Retail Frenzy Triggers Max Clawback

Joy Spreader Interactive Technology (6988 HK) (JST) is looking to raise up to US$225m in its upcoming Hong Kong IPO. JST is a performance-based...

Share
22 Jul 2020 05:39

HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities

Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...

Logo
771 Views
Share
12 Jul 2020 15:57

ECM Weekly (12 July 2020) - Ocumension and Smoore, Simcere, Blue Moon, Weihai City Bank, Radiance

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...

Share
x